Can You Take Flexeril with Metoprolol Succinate?
Yes, cyclobenzaprine (Flexeril) can generally be taken with metoprolol succinate, but this combination requires caution due to potential additive cardiovascular effects, particularly hypotension and bradycardia.
Key Safety Considerations
Cardiovascular Monitoring Required
The primary concern with combining these medications is additive cardiovascular depression. Both agents can cause:
- Hypotension
- Bradycardia
- Dizziness and sedation
While there is no absolute contraindication documented in FDA labeling or major guidelines, the combination warrants careful monitoring, especially when initiating therapy 1.
Specific Risks with Cyclobenzaprine
Cyclobenzaprine is structurally related to tricyclic antidepressants and carries similar cardiovascular risks 1. The FDA label specifically warns that cyclobenzaprine can produce:
- Arrhythmias
- Sinus tachycardia
- Prolongation of cardiac conduction
Cyclobenzaprine is contraindicated in patients with arrhythmias, heart block, conduction disturbances, congestive heart failure, or during acute myocardial infarction 1. If you're taking metoprolol for any of these conditions, cyclobenzaprine should be avoided entirely.
Drug Interaction Mechanism
The interaction is primarily pharmacodynamic (additive effects) rather than pharmacokinetic. Metoprolol is metabolized by CYP2D6 2, 3, while cyclobenzaprine does not significantly inhibit this enzyme. However, cyclobenzaprine does enhance the effects of CNS depressants 1, which could compound the sedative and hypotensive effects when combined with beta-blockers.
Clinical Recommendations
When This Combination May Be Acceptable
- Stable cardiovascular status: Normal blood pressure, heart rate >60 bpm, no history of heart block or arrhythmias
- Short-term use: Cyclobenzaprine is typically prescribed for acute musculoskeletal conditions (2-3 weeks maximum)
- Low doses: Starting with the lowest effective dose of cyclobenzaprine (5 mg) rather than higher doses
Monitoring Parameters
If prescribed together, monitor for:
- Blood pressure (watch for hypotension, especially orthostatic)
- Heart rate (watch for excessive bradycardia <50 bpm)
- Dizziness, lightheadedness, or syncope
- Excessive sedation
When to Avoid This Combination
Do not combine if you have:
- Recent myocardial infarction
- Heart block or conduction abnormalities
- Arrhythmias
- Congestive heart failure
- Hypotension or symptomatic bradycardia
- Elderly age (>65 years) - cyclobenzaprine is not recommended 1
Perioperative Considerations
According to SPAQI consensus guidelines, cyclobenzaprine should be held on the day of surgery 4. This is relevant if you're taking metoprolol for perioperative cardiac protection.
Special Populations
Elderly Patients
Cyclobenzaprine plasma levels increase by 40% and half-life by 56% in elderly patients. The FDA specifically states cyclobenzaprine is not recommended in elderly patients 1. Given that metoprolol is commonly prescribed in older adults for hypertension and heart disease, this combination should generally be avoided in this population.
Hepatic Impairment
Cyclobenzaprine levels double in patients with hepatic impairment, and use is not recommended in any degree of liver dysfunction 1.
Alternative Approaches
If muscle relaxation is needed while on metoprolol:
- Consider physical therapy, heat/ice, or NSAIDs first
- Methocarbamol or metaxalone may have less cardiovascular interaction risk 4
- Avoid carisoprodol due to abuse potential and cardiovascular effects 4, 5
Bottom Line
The combination is not absolutely contraindicated but requires clinical judgment based on your cardiovascular status. If your metoprolol is for simple hypertension with stable vital signs and no structural heart disease, short-term cyclobenzaprine at low doses may be acceptable with monitoring. However, if metoprolol is prescribed for heart failure, arrhythmias, or post-MI, cyclobenzaprine should be avoided. Always discuss with your prescribing physician before combining these medications.